Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
Open Access
- 13 February 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 621
Abstract
Neurological diseases (NDs) are a significant cause of disability and death in the global population. However, effective treatments still need to be improved for most NDs. In recent years, cell-membrane-coated nanoparticles (CMCNPs) as drug-targeting delivery systems have become a research hotspot. Such a membrane-derived, nano drug-delivery system not only contributes to avoiding immune clearance but also endows nanoparticles (NPs) with various cellular and functional mimicries. This review article first provides an overview of the function and mechanism of single/hybrid cell-membrane-derived NPs. Then, we highlight the application and safety of CMCNPs in NDs. Finally, we discuss the challenges and opportunities in the field.Keywords
Funding Information
- National Natural Science Foundation of China (82071336, 82090044, 81820108010, 2018YFC1312200)
- National Key Research and Development Program of China (82071336, 82090044, 81820108010, 2018YFC1312200)
This publication has 153 references indexed in Scilit:
- Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horseCancer Nanotechnology, 2012
- Organically Modified Silica Nanoparticles Are Biocompatible and Can Be Targeted to Neurons In VivoPLOS ONE, 2012
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Polyelectrolyte Complex Optimization for Macrophage Delivery of Redox Enzyme NanoparticlesNanomedicine, 2010
- Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S DiseaseNanomedicine, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDSThe Journal of Immunology, 2009
- Cancer Cell CyclesScience, 1996